Lipid management in diabetic patients: lessons from prevention trials

This publication has 23 references indexed in Scilit:

• Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
  New England Journal of Medicine, 2002
• Peroxisome Proliferator–Activated Receptor γ and Metabolic Disease
  Annual Review of Biochemistry, 2001
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
• Inhibition of proinflammatory cytokine production by pravastatin
  The Lancet, 1999
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
  New England Journal of Medicine, 1998
• Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
  Diabetes Care, 1997
• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• Coronary Heart Disease Incidence in NIDDM Patients In The Helsinki Heart Study
  Diabetes Care, 1992